NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lentitek

Lentitek

Private
EdinburghHealthcare & Life Scienceshttps://lentitek.com/

Last Round

Seed

Mar 5, 2025

Total Funding Raised

$1.69M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lentitek is a biotechnology company that develops manufacturing technologies to enhance the quality, yield, and compatibility of lentiviral vectors used in advanced therapies such as cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

lentiviral vectorgene deliverygene therapycell therapycell and gene therapyviral vector manufacturingbioprocessingCGTviral vector productionCDMOcontract development and manufacturing organizationbiotech CROvector engineeringviral vector platformbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lentitek Comps

Public and private peers based on sector, stage, and business model.

Lentitek comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lentitek Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 5, 2025
GrantAug 28, 2024
SeedMay 30, 2023
GrantJun 13, 2022

Lentitek Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    Integrated technologies with ViroCell Biologics Ltd. for lentiviral vector manufacturing.

  • Mar 24, 2026

    PR Fire Limited selected for intelligent vector development.

Lentitek Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lentitek Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lentitek's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range9
Year Founded2019
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.